Howard Dorfman to Address ACI Forum on Advertising and Promotions for the Pharmaceutical Industry
The Carton HotelNew York,
NY
Howard Dorfman, counsel in the Life Sciences practice group of Ropes & Gray, will address the American Conference Institute's upcoming Corporate Counsel Forum on Advertising and Promotions for the Pharmaceutical Industry in New York. Forum topics will include:
Examining restrictions on pharmaceutical manufacturer activities
Case studies of inequitable conduct
Consequences of receipt of a warning or untitled letter for pre-approval promotion
Managing regulatory limitations on pre-approval company activities during the final stages of FDA review
Advising the healthcare community of imminent product availability while remaining compliant
Reviewing FDA regulatory activity and establishing appropriate in-house compliance and education processes
Maintaining an acceptable separation of science and promotion in press releases announcing clinical trial results
Presenting clinical trial data in a scientific and objective manner
Guidance on scientific exchange
Beyond FDA – the increasing oversight by the Department of Justice, the OIG, and the SEC